TABLE 1.
Overall percent susceptible and MICmin, MIC50, MIC90, and MICmax for imipenem-relebactam and comparatorsa
| Agent | No. susceptible (% of 203) | MICmin | MIC50 | MIC90 | MICmax |
|---|---|---|---|---|---|
| I-R | 180 (89) | ≤0.03 | 0.25 | >256 | >256 |
| IPM | 90 (44) | 0.125 | 2 | >256 | >256 |
| MEM | 153 (75) | ≤0.03 | 0.5 | >4 | >4 |
| ETP | 7 (3) | ≤0.016 | >2 | >2 | >2 |
| GEN | 132 (65) | 0.25 | 1 | >16 | >16 |
| TZP | 56 (28) | ≤1 | 128 | >128 | >128 |
| AMK | 163 (80) | ≤0.5 | 4 | >64 | >64 |
| LVX | 40 (20) | ≤0.06 | >8 | >8 | >8 |
| TGC | 200 (99) | 0.25 | 0.5 | 8 | 8 |
| CAZ | 19 (9) | ≤0.125 | 32 | >256 | >16 |
| CL | 201 (99) | ≤0.06 | 0.125 | 8 | 8 |
| MIN | 141 (69) | 0.5 | 4 | >16 | >16 |
a
MICmin, lowest detected MIC; MICmax, highest detected MIC; AMK, amikacin; CAZ, ceftazidime; CL, colistin; ETP, ertapenem; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; TGC, tigecycline; TZP, piperacillin-tazobactam.